Explained herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate medicines, these devices such as a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with incredibly reduced permeability to oxygen and com